X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs GSK PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS GSK PHARMA J.B.CHEMICALS/
GSK PHARMA
 
P/E (TTM) x 17.7 49.5 35.7% View Chart
P/BV x 2.2 10.2 21.8% View Chart
Dividend Yield % 0.5 2.8 18.7%  

Financials

 J.B.CHEMICALS   GSK PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
GSK PHARMA
Mar-18
J.B.CHEMICALS/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs3632,760 13.2%   
Low Rs2552,040 12.5%   
Sales per share (Unadj.) Rs169.1339.0 49.9%  
Earnings per share (Unadj.) Rs16.641.4 40.1%  
Cash flow per share (Unadj.) Rs23.445.9 51.0%  
Dividends per share (Unadj.) Rs2.0035.00 5.7%  
Dividend yield (eoy) %0.61.5 44.4%  
Book value per share (Unadj.) Rs172.5242.9 71.0%  
Shares outstanding (eoy) m83.5784.70 98.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.87.1 25.8%   
Avg P/E ratio x18.657.9 32.1%  
P/CF ratio (eoy) x13.252.3 25.2%  
Price / Book Value ratio x1.89.9 18.1%  
Dividend payout %12.084.5 14.3%   
Avg Mkt Cap Rs m25,827203,280 12.7%   
No. of employees `0003.8NA-   
Total wages/salary Rs m2,5115,234 48.0%   
Avg. sales/employee Rs Th3,747.4NM-  
Avg. wages/employee Rs Th665.7NM-  
Avg. net profit/employee Rs Th367.8NM-  
INCOME DATA
Net Sales Rs m14,13528,715 49.2%  
Other income Rs m366545 67.1%   
Total revenues Rs m14,50129,260 49.6%   
Gross profit Rs m2,1785,059 43.1%  
Depreciation Rs m570380 149.9%   
Interest Rs m352 1,745.0%   
Profit before tax Rs m1,9405,222 37.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0178 0.0%   
Tax Rs m5521,892 29.2%   
Profit after tax Rs m1,3873,508 39.5%  
Gross profit margin %15.417.6 87.5%  
Effective tax rate %28.536.2 78.6%   
Net profit margin %9.812.2 80.3%  
BALANCE SHEET DATA
Current assets Rs m10,47021,815 48.0%   
Current liabilities Rs m2,74915,999 17.2%   
Net working cap to sales %54.620.3 269.7%  
Current ratio x3.81.4 279.3%  
Inventory Days Days5564 86.8%  
Debtors Days Days7819 415.6%  
Net fixed assets Rs m5,81112,475 46.6%   
Share capital Rs m167847 19.7%   
"Free" reserves Rs m14,24819,726 72.2%   
Net worth Rs m14,41620,573 70.1%   
Long term debt Rs m06 0.0%   
Total assets Rs m17,64939,475 44.7%  
Interest coverage x56.62,612.0 2.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.7 110.1%   
Return on assets %8.18.9 90.6%  
Return on equity %9.617.1 56.4%  
Return on capital %13.726.2 52.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,164564 1,092.9%   
Fx outflow Rs m1,3347,429 18.0%   
Net fx Rs m4,829-6,865 -70.3%   
CASH FLOW
From Operations Rs m1,2314,728 26.0%  
From Investments Rs m-208-1,042 20.0%  
From Financial Activity Rs m-595-3,066 19.4%  
Net Cashflow Rs m427620 68.9%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 50.7 0.6%  
Indian inst/Mut Fund % 3.4 10.2 33.2%  
FIIs % 3.9 23.8 16.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 15.4 240.3%  
Shareholders   30,437 102,036 29.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   FULFORD INDIA  VENUS REMEDIES  STERLING BIOTECH  CADILA HEALTHCARE  AUROBINDO PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 66 Points Higher; Realty and Consumer Durable Stocks Witness Buying(Closing)

Indian share markets continued to witness volatility during closing hours and ended their day on a flat note.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 16.6% YoY). Sales on the other hand came in at Rs 8 bn (up 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0% (Quarterly Result Update)

Feb 5, 2019 | Updated on Feb 5, 2019

For the quarter ended December 2018, GSK PHARMA has posted a net profit of Rs 1 bn (up 26.0% YoY). Sales on the other hand came in at Rs 8 bn (up 17.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 19, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - VENUS REMEDIES COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS